CAS RN: 2092357-48-5
Pyridazine, 3-bromo-5-chloro-
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251204
50mg / 100mg / 250mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2092357-48-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
2092357-48-5 / 3-bromo-5-chloropyridazine
Standard CAS: 2092357-48-5
Multi CAS: No
Basic Information
copy
CAS
2092357-48-5 copy
Multi CAS
No copy
Molecular Formula
C4H2BrClN2 copy
Molecular Weight
193.430000 copy
Exact Mass
191.908990 copy
SMILES
C1=C(C=NN=C1Br)Cl copy
InChI
InChI=1S/C4H2BrClN2/c5-4-1-3(6)2-7-8-4/h1-2H copy
InChIKey
HAFSOSNTDNHREJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
8 copy
Aromatic heavy atom count
6 copy
H-bond acceptors
2 copy
Molar refractivity
34.74 copy
TPSA
25.78 copy
LogP / Solubility
WLOGP
1.89 copy
MLOGP
1.66 copy
XLogP3
1.5 copy
Consensus LogP
1.68 copy
Log S (ESOL)
-2.79 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.51 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.49 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.56 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy